{"id":32,"date":"2007-09-13T13:35:10","date_gmt":"2007-09-13T17:35:10","guid":{"rendered":"https:\/\/www.bumc.bu.edu\/clinicaltrials\/cto\/thalassemia-protocol-information\/"},"modified":"2024-09-25T08:10:29","modified_gmt":"2024-09-25T12:10:29","slug":"cutaneous","status":"publish","type":"page","link":"https:\/\/www.bumc.bu.edu\/clinicaltrials\/cutaneous\/","title":{"rendered":"Cutaneous"},"content":{"rendered":"<h3 style=\"text-align: center;\">Melanoma:<\/h3>\n<p><a href=\"https:\/\/clinicaltrials.gov\/ct2\/show\/NCT04462406?term=NCT04462406&amp;draw=2&amp;rank=1\"><strong>CIRB #H-41279\/ CTSU #EA6191 (PET-stop)<\/strong>: <\/a>A Phase II Study of Biomarker Driven Early Discontinuation of Anti-PD-1 Therapy in Patients with Advanced Melanoma (PET-Stop)<\/p>\n<h3 style=\"text-align: center;\">Kaposi Sarcoma:<\/h3>\n<p><a href=\"https:\/\/clinicaltrials.gov\/ct2\/show\/NCT04577755?term=NCT04577755&amp;draw=2&amp;rank=1\"><strong>CIRB #H-42705\/ AMC #108<\/strong>: <\/a>Multicenter Phase II Study of Pomalidomide Monotherapy in Kaposi Sarcoma<\/p>\n<h3 style=\"text-align: center;\">Metastatic\/Advanced 2nd+ Line Solid Tumors:<\/h3>\n<p><em>KRAS\/NRAS\/HRAS\/BRAF positive<\/em><br \/>\n<a href=\"https:\/\/clinicaltrials.gov\/ct2\/show\/NCT05111561?term=NCT05111561&amp;draw=2&amp;rank=1\"><strong><strong>CIRB #H-42956\/ ETCTN #10449:<\/strong><\/strong><\/a> A Phase 1 Study of ZEN003694 in Combination with Binimetinib in Solid Tumors with RAS Pathway Alterations and Triple Negative Breast Cancer <b>(temporary closure)<\/b><\/p>\n","protected":false},"excerpt":{"rendered":"<p>Melanoma: CIRB #H-41279\/ CTSU #EA6191 (PET-stop): A Phase II Study of Biomarker Driven Early Discontinuation of Anti-PD-1 Therapy in Patients with Advanced Melanoma (PET-Stop) Kaposi Sarcoma: CIRB #H-42705\/ AMC #108: Multicenter Phase II Study of Pomalidomide Monotherapy in Kaposi Sarcoma Metastatic\/Advanced 2nd+ Line Solid Tumors: KRAS\/NRAS\/HRAS\/BRAF positive CIRB #H-42956\/ ETCTN #10449: A Phase 1 Study [&hellip;]<\/p>\n","protected":false},"author":2,"featured_media":0,"parent":0,"menu_order":12,"comment_status":"closed","ping_status":"closed","template":"","meta":[],"_links":{"self":[{"href":"https:\/\/www.bumc.bu.edu\/clinicaltrials\/wp-json\/wp\/v2\/pages\/32"}],"collection":[{"href":"https:\/\/www.bumc.bu.edu\/clinicaltrials\/wp-json\/wp\/v2\/pages"}],"about":[{"href":"https:\/\/www.bumc.bu.edu\/clinicaltrials\/wp-json\/wp\/v2\/types\/page"}],"author":[{"embeddable":true,"href":"https:\/\/www.bumc.bu.edu\/clinicaltrials\/wp-json\/wp\/v2\/users\/2"}],"replies":[{"embeddable":true,"href":"https:\/\/www.bumc.bu.edu\/clinicaltrials\/wp-json\/wp\/v2\/comments?post=32"}],"version-history":[{"count":13,"href":"https:\/\/www.bumc.bu.edu\/clinicaltrials\/wp-json\/wp\/v2\/pages\/32\/revisions"}],"predecessor-version":[{"id":5502,"href":"https:\/\/www.bumc.bu.edu\/clinicaltrials\/wp-json\/wp\/v2\/pages\/32\/revisions\/5502"}],"wp:attachment":[{"href":"https:\/\/www.bumc.bu.edu\/clinicaltrials\/wp-json\/wp\/v2\/media?parent=32"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}